As verified recently, TP53 and ATRX mutations were the hallmark of 1p19q intact IDH1-mutated gliomas, while CIC and FUBP1 mutations were found in 1p19q co-deleted gliomas [20–22]. This evidence concerns the gene TP53 and central nervous system cancer.